APH Alliance Pharma Plc

TIDMAPH

RNS Number : 6167Y

Alliance Pharma PLC

03 January 2020

 
 For immediate release   3 January 2020 
 

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Total Voting Rights

Alliance Pharma plc (AIM: APH), the international healthcare group, makes the following notification in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1.

As at 31 December 2019 the Company's issued share capital consists of 529,402,619 Ordinary Shares of 1p each.

The total number of voting rights in the Company is 529,402,619 and this figure may be used by shareholders as the denominator for the calculations by which they should determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information:

Alliance Pharma plc + 44 (0) 1249 466966

Peter Butterfield, Chief Executive Officer

Andrew Franklin, Chief Financial Officer

www.alliancepharma.co.uk

Buchanan + 44 (0) 20 7466 5000

Mark Court / Hannah Ratcliff

Numis Securities Limited + 44 (0) 20 7260 1000

Nominated Adviser: Freddie Barnfield

Corporate Broking: James Black

Investec Bank plc +44 (0) 20 7597 5970

Corporate Finance: Daniel Adams / Ed Thomas

Corporate Broking: Patrick Robb / Tejas Padalkar

Notes to editors:

About Alliance Pharma

Alliance, founded in 1998, is an international specialty pharmaceutical group based in Chippenham, Wiltshire, UK. The Group has sales in more than 100 countries worldwide via direct sales, joint ventures and a wide network of distributors. Alliance has a strong track record of acquiring the rights to established niche products and it currently owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products. The Group continues to explore opportunities to expand its product portfolio.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

TVRUPUGWGUPUGMP

(END) Dow Jones Newswires

January 03, 2020 02:00 ET (07:00 GMT)

Grafico Azioni Alliance Pharma (LSE:APH)
Storico
Da Mar 2024 a Apr 2024

Grafico Azioni Alliance Pharma (LSE:APH)
Storico
Da Apr 2023 a Apr 2024